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The present study compares rat liver preservation 
for 9, 12, and 24 h in the standard Eurocollins 
solution with preservation for the same time peri-
ods in the new UW-Iactobionate solution. Pharma-
cologic manipulation with a potent platelet-
activating factor antagonist, SRI 63-441, was also 
evaluated. After cold storage in each of the test 
solutions, the livers underwent 90 min of warm, 
oxygenated, sanguinous perfusion. A significant in-
crease in liver weight was noted in Eurocollins-
stored versus UW -lactobionate-stored livers. After 
90 min of perfusion, livers preserved in UW-
lactobionate produced significantly more bile and 
liberated significantly less glucose and transami-
nases when compared with Eurocollins-stored liv-
ers. Significant augmen,tation of bile production was 
observed when donor animals were pretreated with 
SRI 63-441 and the livers were then stored in 
UW-Iactobionate for 24 h. Eurocollins-stored livers 
demonstrated increased hepatocyte vacuolization 
and endothelial disruption when compared with 
UW-Iactobionate-stored livers after 12 and 24 h of 
preservation. This study demonstrates the superior-
ity of UW-Iactobionate solution in liver preserva-
tion and suggests that SRI 63-441 may be beneficial 
in the further reduction of cold ischemic injury. 
T he development of a technique with the capabil-ity of preserving livers for at least 24-36 h, with 
consistent and good postimplantation function, 
would maximize donor use and ensure better organ 
recipient matching and sharing. Recently, Jamieson 
et al. reported successful transplantation of canine 
livers preserved for >20 h using simple, static 
hypothermic storage in a novel solution, known as 
the UW-lactobionate (UW) solution (1-3). 
In the present study we have further evaluated the 
efficacy of static hypothermic liver preservation in 
UW solution. by comparing it with preservation in 
standard Eurocollins (Ee) solution after 9, 12. and 24 
h of cold storage, Liver function was assessed on an 
isolated perfused rat liver apparatus. modified from 
Miller et al. (4). The results of these studies revealed 
evidence of improved hepatic status in those livers 
preserved in UW solution, with the greatest differ-
ence in treatment groups being exhibited after 24 h 
of preservation. 
Platelet-activating factor (PAF) is a key inflamma-
tory mediator (5-7) implicated in the microcircula-
tory failure that ensues after ischemic organ injury, 
Predously we reported the protective effect of a 
platelet-acti\'ating factor antagonist. SRI 63-441 
(Sandoz Pharmaceuticals. 0.'orth Hanover. :\.J.). on 
postischemic hepatic function after warm ischemic 
injury (8). 
In the present study we have investigated the role 
of PAF antagonism on hepatic function after a cold 
ischemic insult, The results of this study suggest that 
protection of the microvasculature by a combined 
approach utilizing UW solution and SRI 63-441 can 
significantly reduce cold ischemic injury to the liver 
and result in reliable and prolonged extension of the 
preservation period. 
Materials and Methods 
Animals 
Male Lewis rats (Charles River Breeding Laborato-
ries. Wilmington. ~·lassKl weighing 225-300 g were used as 
liver donors. and male Lewis rat retired breeders were 
used as blood donors. Animals were acclimatized for 1 wk 
Abbreviations used in this paper: EC, Eurocollins; PAF, plate-
let.activatirlg factor; UW. UW-Iactobionate. 
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Table 1. Experimental Croups 
Storage time 
Group n (h) 
1° 7 :\0 storage 
2 5 9 
3 6 9 
4 5 12 
5 6 12 
6 6 24 
7 5 24 
8b 6 24 
Solution 
EC 
UW 
EC 
UW 
EC 
UW 
UW 
SRI 63-441 
(20 mg/kg) 
+ 
EC, Eurocollins; UW, UW-Iactobionate. a Livers were flushed 
with lactated Ringer's solution and immediately placed on the 
perfusion apparatus. b Animals were intravenously pretreated 
with 20 mg/kg of SRl 63-441 5 min before harvesting the liver. 
before experimentation, housed in a standard animal fa-
cility at the University of Pittsburgh, and fed standard 
laboratory diet for rats and water ad libitum. 
Operative Procedure 
Inhalational anesthesia was induced and main-
tained with methoxyflurane. All animals received 300 U of 
heparin intravenously via the penile vein 5 min before 
cannulation of the bile duct and portal vein. The bile duct 
and portal vein were cannulated and, after the vena cava 
was vented. the liver was flushed via the portal vein with 
20 ml of cooled (4°q preservation solution from a height of 
20 cm. The liver was excised during the flushing period, 
weighed, immersed in preservation solution, and stored at 
4°C. Before placement on the perfusion apparatus, livers 
were flushed with 8 ml of lactated Ringer's solution to 
remove the preservation solution. 
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Isolated Perfusion 
The perfusion apparatus was a recirculating system 
(4,9,10) maintained at 37°C by a circulating water bath and 
oxygenated with a 95% 0z-5% CO2 mixture. The liver was 
perfused via the portal vein from a height of 18 cm (11). 
The perfusate consisted of a dilute sanguinous solution 
prepared from 2 parts by volume of heparinized fresh 
whole rat blood and 1 part Krebs' bicarbonate buffer (12) at 
a hematocrit of 25 (13) and pH == 7.4. 
Experimental Protocol 
Experimental groups are described in Table 1. After 
storage at 4°C, all livers were flushed with Ringer's lactate 
and placed on the perfusion apparatus for 90 min. 
Platelet-Activating Factor Antagonist 
SRI 63-441. a PAF receptor antagonist, was sup-
plied by Sandoz Pharmaceuticals. It was supplied in a 
powdered form and a 1S-mg/ml solution was prepared 
daily in 0.9% sodium chloride. The solution was warmed 
to 37°C to ensure that the SRI 63-441 was completely 
solubilized before injection. 
Assessment of Liver Status 
Livers were weighed immediately after harvesting 
and after the preservation period. Baseline perfusate levels 
of serum glutamic oxaloacetic transaminase (SGOT), se-
rum glutamic pyruvic transaminase (SGPT), lactic dehy-
drogenase (LDH), and glucose were measured before plac-
ing the liver on the perfusion apparatus. Liver function 
during perfusion was determined by measuring bile pro-
duction and SCOT. SGPT, LDH, and glucose levels in the 
perfusate every 30 min during perfusion. Serum glutamic 
oxaloacetic transaminase. SGPT, LDH, and glucose levels 
~ 12 --1 1--24 --I 
I§§ Eurocolllns ~ UW-Llcloblonal8 ~ UW-Lacloblonale + SRI 63-441 
Figure 1. Percentage change in liver weight during the preservation period. Livers preserved in EC solution gained significantly more 
weight than those preserved in UW solution. The addition of SRI 63-441 did not significantly alter weight change during the 
storage period. 
~t:Scj;¥iSii4;-Kw~Ii"_1s"tiiitDroiiiDifiiifii§"DKDDDtiilifD ... t\Wilii'hWiM-· _. '. 
~" o~DI "I 
.; 
:l 
~~D~ December 1988 
were determined using the Technicon RA 500 (Technicon 
Instruments Corp., Tarrytown, N.Y.). 
..... fter 90 min of warm sanguinous perfusion, the livers 
\\'ere perfuse-fixed via the portal vein with 2.0% glutaral-
dehvde in 0.125 M cacodylate buffer, minced to 1 x 1 x 
f-m~ cubes, and placed in 2.0% glutaraldehyde for 2 h 
(H). The livers were post-fixed in buffered 2.0% osmium 
tetroxide, dehydrated in ethanol. and embedded in Epon 
812. Blocks were cut using a Reichert microtome. Semi-
thin sections were stained with toluidine blue for light 
microscopy. Ultrathin sections were collected on grids, 
stained with uranyl acetate and lead citrate, and observed 
with a Phillips 300 electron microscope (Phillips Elec-
tronic Instruments, Mahwah, N.J.) (15). 
Statistics 
All val ues were corrected to baseline by subtracting 
the \'alues obtained before placing the liver on the perfu-
sion apparatus from subsequent measurements after 30, 
60, and 90 min of perfusion. Statistical evaluation was 
made using analysis of variance and Student's t-test (16). 
All values are expressed as mean ± SEM. Probability 
\'alues of <0.05 were considered statistically significant. 
Results 
Liver Weight 
There was a significant increase in liver 
weight for those organs stored in EC solution when 
compared with UW-stored livers (p < 0.05). There 
were no significant differences in the weights of 
livers stored in UW solution for 24 h regardless of 
pretreatment with SRI 63-441 (Figure 1). 
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Transaminase Release 
Serum glutamic oxaloacetic transaminase val-
ues are presented in Figure 2. Serum glutamic 
oxaloacetic transaminase and sePT liberation into 
the perfusate was significantly higher (p < 0.01) in 
livers preserved in EC solution when compared with 
controls that did not undergo preservation. The 
livers stored in UW solution did not release signifi-
cantly more SCOT into the perfusate than controls 
until after 60 min of perfusion (p < 0.05). Similarly, 
livers preserved in UW solution did not liberate 
significantly more SePT into the perfusate than 
controls, except after 24 h of storage and 90 min of 
perfusion (p < 0.05). The 24-h, UW-stored, SRI 
63-441-pretreated livers did not release significantly 
more SCOT than controls until after 90 min of 
perfusion (p < 0.05). and did not release signifi-
cantly more SePT than controls. 
After 30 min of perfusion, there was no significant 
difference in SCOT release between UW-stored and 
EC-stored livers until after 24 h of preservation (p < 
0.05). Perfusate SCOT levels became significantly 
different between UW-stored and EC-stored livers 
after 60 min of perfusion for those livers preserved 
for 12 and 24 h (p < 0.01). After 90 min of perfusion, 
perfusate SCOT levels were significantly lower for 
UW-stored livers when compared with EC-stored 
livers (p < 0.01). Serum glutamic pyruvic transami-
nase liberation by livers stored in UW solution was 
significantly decreased when compared with livers 
stored in EC solution (p < 0.01). 
Although there was a trend of decreased transam-
50 
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Figure 2. Perfusate SGOT levels. Differences in SCOT liberation into the perfusate are most dramatically demonstrated after 24 h of 
preservation. Serum glutamiC oxaloacetic transaminase release from livers stored for 24 h in UW solution is comparable to the 
values at 9 and 12 h for livers stored in EC solution. Perfusate levels of SGPT, LDH, and glucose, and bile production followed 
a similar pattern. 
1620 01'\TELL ET AL. 
inase release in the SRI 53-441-pretrcated. 24-h UW-
stored livers when compared with 24-h UW-stored 
livers alone. these differences were not statistically 
significant. 
Lactic Dehydrogenase Release 
There was a significant increase in LDH liber-
ation by both UW-stored and EC-stored livers when 
compared \",ith non preserved controls (p < 0.01). 
Li vers from animals pretreated with SRI 53 -441. 
stored in UW solution for 24 h. similarly released 
significantly more LDH than controls (p < 0.01). 
No significant difference was found in perfusate 
LDH levels between livers stored in UW and livers 
stored in EC solution after 9 and 12 h; hovliever. after 
24 h of preservation, there was a significant increase 
in LDH release by livers preserved in EC solution 
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versus those preserved in UW solution (p < 0.01). 
The addition of SRI 63-441 to the protocol did not 
further significantly reduce LDH release in livers 
stored for 24 h in UW solution. 
Perfusate Glucose Levels 
There was a significant increase in perfusate 
glucose levels for those livers stored in EC solution 
when compared with controls (p < 0.01). There was 
no significant increase in perfusate glucose levels for 
livers preserved in UW solution when compared 
with controls until after 24 h of storage (p < 0.01) 
and only after 30 and 60 min of perfusion. There was 
no significant difference in perfusate glucose levels 
between UW-stored livers and controls after 90 min 
of perfusion for all periods of preservation. Although 
there was a significant increase in perfusate glucose 
Figure 3. Low'magnification electron micrographs (x 1700). a. Liver preserved in EC solution for 24 h. 1'\ole extensive vacuolization of 
hepatocytes (ar[ows). b. Liver preserved in UW solution for 24 h. A few small vacuoles are present (arrows). 
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levels for the livers from animals pretreated .. vith SRI 
63-441 and stored in UW solution for 24 h after 30 
min of reperfusion when compared with controls (p 
< 0.01). this difference was no longer statistically 
significant after 60 and 90 min of perfusion. 
There was a significant decrease in perfusate glu-
cose levels for livers stored in UW solution when 
compared with EC-stored livers (p < 0.05). except 
for those livers stored in UW solution for 24 hand 
only after the 30- and 60-min perfusion periods. SRI 
63-441 pretreatment resulted in no further signifi-
cant reduction in perfusate glucose levels over livers 
stored in UW solution alone. 
Bile Production 
Bile production results followed a pattern 
similar to that seen for transaminase release. Livers 
~ ( . 
, 
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presen'ed in EC solution produced significantly less 
bile than immediately perfused non preserved con-
trols (p < 0.01). Bile production by UW·stored livers 
was not significantly reduced from non preserved 
controls until the 24-h preservation period (p < 
0.01). There was a significant increase in bile pro-
duction by the livers preserved in UW solution when 
compared with EC-preserved livers (p < 0.01]. Liv-
ers harvested from rats pretreated with 20 mg/kg of 
SRI 63-441 intravenously and stored in UW solution 
for 24 h produced significantly more bile than livers 
preserved in the UW solution alone (p < 0.05). 
\forphologic E\'oluation 
Light and low-magnification electron micros-
copy revealed extensive vacuolization of hepato-
cytes in the 24-h EC-preserved lh'ers (Figure 30) 
- K~ 
.-
Figure 4. Electron micrographs after 24·h preservation (X9700). o. Liver preserved in EC solution for 24 h. Note ;\\'ollen mitochondria 
(.'.1), vacuoles (V). and endothelial disruption (arrows). b. Liver preserved in U\\' solution for 24 h. :\ote areas of intact 
endothelium (E). Areas of endothelial injury were also present (not shown). 
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when compared with controls and with livers pre-
served in UW for 24 h (Figure 3b) regardless of 
pretreatment with SRI 63-441. Vacuolization \vas 
present to a minor extent in the 9- and 12-h EC-
preserved livers and rarely present in the 9- and 12-h 
UW-preserved livers (not shown). 
Electron microscopy revealed extensive sinusoi-
dal endothelial disruption in livers stored in EC for 
24 h (Figure 40). Livers preserved in UW solution for 
24 h also exhibited some endothelial damage in the 
sinusoids, but to a lesser extent than EC-stored livers 
(Figure 4b). The sinusoidal endothelium of livers 
preserved in UW for 9 h could not be distinguished 
from the sinusoidal endothelium of nonpreserved 
control livers; however, 9-h EC-preserved livers 
manifested a minor degree of endothelial damage 
(not shown). After 12 h of preservation, both EC- and 
UW-stored livers exhibited areas of sinusoidal endo-
thelial damage interspersed with areas containing 
intact sinusoidal endothelium when compared with 
controls; however, the endothelium appeared to be 
better preserved in the livers stored in UW solution 
(not shown). Livers that were pretreated with SRI 
63-441 and stored in UW solution for 24 h did not 
demonstrate any discernable histologic improve-
ment over the livers stored in UW alone for 24 h (not 
shown). 
Discussion 
Before the development of UW solution, there 
had been a resurgence of interest and enthusiasm in 
hypothermic perfusion as the method best suited for 
prolonged hepatic preservation (17-19). Simple 
hypothermic preservation of the rat liver using iso-
tonic citrate was much less successful than that 
obtained by continuous hypothermic perfusion 
(20,21). The consistently successful transplantation 
of canine livers after 24-30 h of cold storage in UW 
solution reported by Jamieson et al. (1) is a landmark 
event in liver preservation. In the present study we 
have evaluated hepatic function after 9, 12, and 24 h 
of preservation with UW solution using the isolated 
perfused rat liver. 
A substantial improvement in hepatic function, 
compared with livers stored in conventional EC 
solution, was demonstrated in UW-stored organs 
after 90 min of perfusion, as manifested by increased 
bile production, decreased transaminase release, and 
decreased glucose release into the perfusate. A sig-
nificant difference in perfusate LDH levels between 
EC- and UW-stored livers only became evident after 
24 h of preservation. 
Tamaki et al. (22) observed that livers that gained 
the least weight during preservation resumed a nor-
mal color and consistency more rapidly, did not 
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become congested or bleed, and had the best his-
tologic appearance after revascularization and trans-
plantation. In agreement with the experiments of 
Tamaki et aI., the UW-stored livers gained less 
weight than the EC-stored livers and demonstrated 
the best function after preservation. 
Preliminary results from our laboratory, compar-
ing liver preservation in the standard EC solution 
with the new UW solution using orthotopic liver 
transplantation in the rat, demonstrate improved 
graft survival in those rats receiving livers preserved 
in UW solution after 9 and 24 h of preservation (Liu 
T, personal communication). These initial transplan-
tation findings confirm our observations of the im-
proved status of the isolated perfused rat livers that 
were stored in UW solution. 
Controls that did not undergo any period of pres-
ervation, but under-went the same method of fixa-
tion, exhibited completely intact endothelium in 
both the sinusoids and larger vessels, indicating that 
the changes seen in the experimental groups were 
not artifactual. The endothelial disruption seen most 
dramatically in the sinusoids of the livers stored for 
24 h in EC solution may be the result of (a) true 
endothelial denudation during the reperfusion pe-
riod or (b) a deterioration of the endothelium's 
ability to adhere due to ischemia/reperfusion injury, 
thus allowing its disruption during the process of 
fixation. The degree of endothelial injury observed 
in the preserved livers correlated well with the 
degree of hepatic dysfunction manifested by the 24-h 
EC-stored livers. A correlation between liver dys-
function and severe endothelial disruption has been 
reported by McKeown et al. (23). The importance of 
endothelial injury after ischemialreperfusion has 
also been reported in other organs (24,25). 
The livers preserved in EC solution for 24 h 
exhibited severe hepatocytic vacuolar degeneration, 
which is characteristic of hypoxic injury (26,27). The 
severe hepatocellular injury was evident only in the 
24-h EC-stored livers, whereas endothelial injury 
was present to some extent even after 12 h of EC 
preservation. It appears that the injury to the sinu-
soidal endothelium is an early event in ischemiai 
reperfusion injury and that the ensuing microcircu-
latory failure then results in parenchymal hypoxia 
and vacuolar degeneration. 
Attempts to prevent or diminish ischemic injury 
associated with organ procurement and preservation 
have involved the utilization of several pharmaco-
logic agents (28-31). The PAF antagonist SRI 63-441 
has been shown to have a protective effect on post-
ischemic hepatic function after warm ischemic in-
jury (8). In addition to its effects on platelets, PAF 
induces neutrophil aggregation and activation and 
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superoxide anion release. and acts directly on vas-
cular endothelium to increase permeability (32). Rat 
platelets are thought to be unresponsive to PAF 
(33.34). therefore PAF-mediated ischemic liver in-
jury may be neutrophil-dependent. 
The 24-h UW-stored livers from animals pretreat-
ed with 20 mg/kg of SRI 63-441 produced signifi-
cantly more bile than livers similarly stored from 
untreated animals. This is a notable improvement in 
hepatic synthetic function. Although the other pa-
rameters of liver function evaluated in this study did 
not reach statistical significance. a sustained general 
trend toward improvement was evident for all vari-
ables. 
In summary. the results of this study provide 
objective data to further substantiate the superiority 
of UW solution over EC solution in liver preserva-
tion. Pretreatment of donors with SRI 63-441 is also 
beneficial in the further reduction of cold ischemic 
injury. resulting in improved postischemic hepatic 
function. The isolated perfused rat liver has proved 
to be an excellent model for the study of hepatic 
function after preservation. as it correlates well with 
the technically more difficult in vivo studies. 
References 
1. Jamieson NV, Sundberg R. Lindell S. et al. Successful 24-30 
hour preservation of the canine liver: a preliminary report. 
Transplant Proc 1988:20:945-7. 
2. Wahlberg JA, Southard JH, Belzer FO. Development of a cold 
storage solution for pancreas preservation. Cryobiology 1986: 
23:477-82. 
3. Wahlberg JA. Love R. Landegaard L. Southard JH. Belzer FO. 
n-Hour preservation of the canine pancreas. Transplantation 
1987:43:5-8. 
4. Miller LL. Bly CG. Watson ~fiK et al. The dominant role of the 
liver in plasma protein synthesis. J Exp Med 1951:94:431-53. 
5. Snyder F. Chemical and biochemical aspects of platelet 
activating factor: a novel class of acetylated ether-linked 
choline-phospholipids. Med Res Rev 1985:5:107--40. 
6. Vargaftig BB. Chignard ~1K Benveniste J. Lefort J. Wal F. 
Background and present status of research on platelet activat-
ing factor (PAF-acether). Ann r-.:y Acad Sci 1981:370:119-37. 
7. Bussolino F. Biffignandi P. Arese P. Platelet activating fac-
tor-a powerful lipid autocoid possibly involved in microan-
giopathy. Acta HaematoI1986:75:129--40. 
8. Ontell SJ, Makowka L. Ove P. Starzl TE. The effects of a 
platelet activating factor antagonist on post ischemic hepatic 
function in the rat. Surg Forum 1987:38:388-9. 
9. Hamilton RL. Berry Mr-.:. Williams ~fCK A simple and inex-
pensive membrane lung for small organ perfusion. J Lipid Res 
1974:15:182-6. 
10. Ontell SJ, Colella MS. Horowitz J, Makowka L. Trager I. Starzl 
TE. Applications of the isolated perfused rat liver in trans-
plantation research. J Invest Surg 1988:1:25-7. 
11. Levine RA. Pesh LA, Klatskin G, Giarman NJ. Effect of 
serotonin on glycogen metabolism in isolated rat liver. J Clin 
Invest 1964:43:797-809. 
12. Krebs HA, Henseleit K. Untersuchungen uber die Harnstoff-
*f J5ii 11 eep'Z'''bjOjWi 
24-HOUR LIVER PRESERVA nON IN THE RAT 1623 
bildung im Tierkorper. Hoppe-Seyler's Z Physiol Chern 1932; 
210:33-66. 
13. Riedel GL, Scholle JL. Shepherd AP. Ward WF. Effects of 
hematocrit on oxygenation of the isolated perfused rat liver. 
Am Physiol Soc 1983:345:G769-74. 
14. Fahimi HD. Perfusion and immersion fixation of rat liver with 
glutaraldehyde. Lab Invest 1967:16:735-51. 
15. Reynolds ES. The use of lead citrate at high pH as an electron 
opaque stain in electron microscopy. J Cell Bioi 1963:17:208-
12. 
16. Sokal RR, Rohlf FJ. Biometry: the principles and practice of 
statistics in biological research. 2nd ed. San Francisco: WH 
Freeman, 1981. 
17. Petrie CR, Woods JE. Successful 24 hour preservation of the 
canine liver. Arch Surg 1973;107:461--4. 
18. Sung DTW, Woods JE. 48 Hour preservation of the canine 
liver. Ann Surg 1974;179:422-6. 
19. Toledo-Pereyra LH. Twenty-four hour liver preservation by 
hypothermic intermittent perfusion. Transplantation 1979; 
24:291-3. 
20. Tamaki T, Kamada r-.:. Wight DG, Pegg DE. Hypothermic 
preservation of the rat liver assessed by orthotopic transplan-
tation. II. Evaluation of citrate solutions. Transplantation 
1987;43:357-61. 
21. Tamaki T. Kamada N. Wight DG, Pegg DE. Successful 48-hour 
preservation of the rat liver by continuous hypothermic 
perfusion with Haemaccel-isotonic citrate solution. Trans-
plantation 1987:43:468-71. 
22. Tamaki T, Kamada r-.:. Pegg DE. Hypothermic preservation of 
the rat liver assessed by orthotopic transplantation. A com-
parison of flush solutions. Transplantation 1986:4:395-7. 
23. McKeown CMB, Edwards V, Phillips MJ, Harvey PRC, 
Petrunka CN, Strasberg SM. The critical injury in cold pres-
ervation of liver allografts in the rat is sinusoidal lining cell 
damage. Transplantation 1988 (In press). 
24. Suval WD, Duran Wr-.:. Boric MP, et al. Microvascular trans-
port and endothelial cell alterations preceding skeletal mus-
cle damage in ischemia and reperfusion injury. Am J Surg 
1987:154:211-8. 
25. Kloner RA. Ganote CEo Jennings RB. The "no-reflow" phe-
nomenon after temporary coronary occlusion in the dog. J 
Clin Invest 1974:54:1495-508. 
26. Ashford TP. Burdett!' \\'J. Response of the isolated perfused 
hepatic parenchyma to hypoxia. Ann Surg 1965:162:191-207. 
27. Nakata K. Fukumoto O. Fujimoto K. Fujikawa Y. Develop-
ment of hypoxic change of the liver cells as revealed by the 
isolated perfused rat liver. Acta Pathol Jpn 1971;21:313-28. 
28. Monden M, Fortner JG. 24 and 48 hour canine liver preser-
vation by simple hypothermia with prostacyclin. Ann Surg 
1982:196:38--42. 
29. Atalla SL. Toledo-Pereyra LH. Mackenzie GH, Cederna JP. 
Influence of oxygen derived free radical scavengers on ische-
mic livers. Transplantation 1985;40:584-9. 
30. Arthur MJP. Bently IS. Tanner AR, et al. Oxygen derived free 
radicals promote hepatic injury in the rat. Gastroenterology 
1985:89:1114-22. 
31. Rizzuti RP. Cunningham PRo Easley 0, Fushiki T, Thomas FT. 
A new method of hepatic preservation using pulsatile perfu-
sion and allopurinol. Curr Surg 1986:November-December: 
492-4. 
32. Pinckard RN. Platelet-activating factor. Hosp Pract 1983;18: 
67-76. 
33. Saunders RN, Handley DA. Platelet-activating factor antago-
nists. Ann Rev Pharmacal ToxicoI1987;27:237-55. 
34. Sanchez-Crespo M, Alonso F, Inarrea p, Vlvarez V, Egido J. 
Vascular actions of synthetic PAF-acether (a synthetic plate-
1624 l~qbii ET AL. 
let-activating fdetor) in the rat: nidence for a platelet inde-
pendent mechanism. Immunopharmacology 1982:4:173-85. 
Received March 21. 1988. f\ccepted July 1.1988. 
Address requests for reprints to: Thomas E. Starz!, \1.0 .. Ph.D .. 
F:\CS. Department of Surgery. 3601 Fifth Avenue. Falk Clinic <I 
West. Pittsburgh. Pennsykania 15213 
This work was supported by research grants from the Veterans 
;\dministration. The Children's Liver Foundation. The Competi-
dApqolb~qbolildv Vo!' 95. No 6 
tive Medical Research Fund of Presbyterian Hospital. Pittsburgh. 
Pennsylvania. and project grant AM-29961 from the National 
Institutes of Health. Bethesda. Maryland. 
Sheryl J. Ontell is an Allen Scholar. Elizabeth Severance 
Prentiss Foundation. Department of Surgery. Case Western Re-
serve Uni\·ersity. CIe\·eland. Ohio. 
The authors thank Gloria DiLuiso and Mary Watash for excel-
lent technical assistance. Dr Floyd Taylor of the Department of 
Community \1edicine for assistance with the statistical analysis. 
and Donna Ross for typing the manuscript. 
